"
Team:Oxford/references2
From 2014.igem.org
| Line 7: | Line 7: | ||
<h2> Chlorinated Solvents </h2> | <h2> Chlorinated Solvents </h2> | ||
<p><font style="vertical-align: super; font-size: 70%;">1</font> http://download.springer.com/static/pdf/195/art%253A10.1007%252FBF02987485.pdf?auth66=1407495087_ae638ec384c0ed8f2a6b0855567445cc&ext=.pdf </p> | <p><font style="vertical-align: super; font-size: 70%;">1</font> http://download.springer.com/static/pdf/195/art%253A10.1007%252FBF02987485.pdf?auth66=1407495087_ae638ec384c0ed8f2a6b0855567445cc&ext=.pdf </p> | ||
| + | |||
| + | <h2>Environmental Impact</h2> | ||
| + | <p><font style="vertical-align: super; font-size: 70%;">1</font> | ||
| + | Agency for Toxic Substances and Disease Registry (ATSDR). 2000. Toxicological profile for Methylene Chloride. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service. | ||
<h2> Intellectual Property </h2> | <h2> Intellectual Property </h2> | ||
Revision as of 11:30, 4 September 2014
References
Chlorinated Solvents
1 http://download.springer.com/static/pdf/195/art%253A10.1007%252FBF02987485.pdf?auth66=1407495087_ae638ec384c0ed8f2a6b0855567445cc&ext=.pdf
Environmental Impact
1 Agency for Toxic Substances and Disease Registry (ATSDR). 2000. Toxicological profile for Methylene Chloride. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
Intellectual Property
<p>1 http://www.oecd.org/sti/futures/long-termtechnologicalsocietalchallenges/40181372.pdf2 Gold et al., “Unexamined Assumptions”, supra note 4 at 303-04, citing M. Schankerman, “How Valuable Is Patent Protection? Estimates By Technology Field” (1998) 29:77 RAND J. of Economics 77; M. Schankerman & A. Pakes, “Estimates of the Value of Patent Rights in European Countries During the Post-1950 Period” (1986) 96 The Economic Journal 1052; E. Mansfield, M. Schwartz & S. Wagner, “Imitation Costs and Patents: An Empirical Study” (1981) 91 The Economic Journal 907.
3 E. Richard Gold et al., “The Unexamined Assumptions of Intellectual Property: Adopting an Evaluative Approach to Patenting Biotechnological Innovation” (2004) 18 Public Affairs Quarterly 299 [hereinafter Gold et al., “Unexamined Assumptions”].
